World Malaria Day

World Malaria Day

25 April 2023
Woman smiling with baby on orange color-treated background

This World Malaria Day is the perfect time to recognize that defeating malaria is crucial to achieving equity and health for all.   

We have 7 years left to eliminate malaria. We can do it if we join forces!

We invite you to read, download and share the content from MMV and partners and also to participate in the global #invest #innovate #implement social media campaign

Check back as this page will continue to be populated throughout the day. 

Man holding boy smiling on purple color-treated background

MMV's social media assets

Help spread the word of the burden of malaria and the need for new, innovative tools. Read, download and share MMV's #WorldMalariaDay social media assets. 

Invest, innovate, implement social media card

RBM Partnership to End Malaria social media kit

This year’s #WorldMalariaDay theme is #TimeToDeliverZeroMalaria. The fight against malaria needs critical attention. If we #invest in malaria control, #innovate new tools, and #implement sustainable approaches, together we can #EndMalaria. Share the message far and wide by downloading and sharing content from the social media kit

Health worker with baby strapped to her back

Devex: Climate change requires adapting malaria prevention campaigns

Preventing disease with seasonally distributed medicines saves lives. In 2022 alone, the intervention protected over 48 million children in 17 countries. But what happens when climate change causes shifts in the malaria season, and therefore the timing and duration of these preventive campaigns? Read the full MMV-authored article on Devex

Girl looking at camera next to her mom

Project Syndicate: Monoclonal Antibodies — A New Weapon Against Malaria

Over the past three years, the COVID-19 pandemic has dominated news headlines and spurred scientific innovation. Innovation in tools to combat malaria should take a page from the pandemic playbook: one benefit of the flood of COVID-19 research is that it demonstrated the enormous potential of monoclonal antibodies. These drugs are artificially synthesized laboratory-made copies of the proteins that a person’s immune system produces to destroy specific foreign invaders. Read the full article on Project Syndicate



Eirini head shot

The Telegraph: Photographer Rankin swaps celebrities for scientists

Acclaimed artist – renowned for his portraits of Kate Moss, Madonna, David Bowie and Queen Elizabeth II – fixes his lens on hidden heroes in science, the "new rock n roll stars of our time." Eirini Tseligka, pharmacology scientist at MMV, is featured in the article posted in The Telegraph

Outside of a malaria clinic

MMV echoes Swiss Malaria Group's call to invest and innovate to end to malaria

On World Malaria Day, the Swiss Malaria Group, of which MMV is a part, calls for more commitment from funders and the international community to combat malaria. Switzerland is a pioneer in innovation: for decades, actors in Switzerland have contributed fundamentally to the development and distribution of drugs, vaccines, diagnostics, bed nets and insecticides. Despite these successes, there is now an annual funding gap of around US$ 3.8 billion. Read the news story and press release.  

Woman smiling with child strapped to her hip

MMV's advertorial published in The Guardian and Media Planet

MMV joined the malaria community in participating in the Media Planet World Malaria Day campaign. We contributed ads published both digitally on the Global Cause website and in print in The Guardian newspaper supplement.  

Girl drinking medicine for seasonal malaria chemoprevention

Voice of Islam radio interview

Voice of Islam discusses malaria and options for prevention, including both vaccines and medicines, with a guest panel. MMV's André-Marie Tchouatieu, Director of Access & Product Management discusses seasonal malaria chemoprevention for children. Visit the podcast webpage to listen. 

Mother, father and child smiling at the camera

WHO stories, messages and social media assets

This World Malaria Day is marked under the theme “Time to deliver zero malaria: invest, innovate, implement." Within this theme, WHO focuses on the third “i” – implement – and notably the critical importance of reaching marginalized populations with the tools and strategies that are available today. Visit the dedicated webpage for stories, key messages and social media assets from WHO. 

Indian woman smiling

Asia Pacific Malaria Elimination Network video

The Asia Pacific Malaria Elimination Network Vivax Working Group video outlines how the group is accelerating progress towards the elimination of Plasmodium vivax malaria, sharing insights and perspectives from National Malaria Programme Managers, experts and stakeholders who are directly involved in the group's work. 

Pregnant woman standing with hair in the wind

Annual Malaria in Pregnancy Working Group meeting video

This video showcases the 2022 RBM Malaria in Pregnancy Working Group (MiPWG) Meeting in Accra, Ghana. The MiPWG is a diverse group of stakeholders that convenes annually to share updates on progress to defeat malaria in pregnancy.

Peruvian family walking over river

Partnership for Vivax Elimination (PAVE) Peru vlog

Here is a video blog from the MMV Peru team following the launch of the PAVE Peru feasibility study in March 2023. The study will examine the feasibility, acceptability, and cost implications of providing primaquine or tafenoquine after G6PD testing in real-world settings. 

Picture of Lima

Peru Ministry of Health World Malaria Day event

Elisa Vidal, MMV's Regional Advisor for Latin America, will be presenting at the Ministry of Health Peru (MINSA) World Malaria Day event on current feasibility studies and new tools to combat Plasmodium vivax malaria. The event will be broadcast in Spanish at the following link:

Belem doc

Brazil Ministry of Health World Malaria Day event

The Brazilian Ministry of Health (MoH) is hosting an event on World Malaria Day to reaffirm the government's commitment to eliminating malaria. The event will include a presentation led by the TRuST Principal Investigator, Marcus Lacerda (FMT) on the key findings of the TRuST study - the first, and biggest real-world study on tafenoquine and G6PD testing.